Log in

SPM SPM Corp. (Vietnam) HOSE · Vietnam

SPM Corp. (Vietnam) (SPM) news

SPM Corp. (Vietnam) is a public biotech or pharmaceutical company listed on HOSE under the ticker SPM, recorded under Vietnam. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest SPM Corp. (Vietnam) news

We have not published a story on SPM Corp. (Vietnam) yet. When there is news, it will appear here.

Questions about SPM Corp. (Vietnam)

What is the ticker symbol of SPM Corp. (Vietnam)?

SPM Corp. (Vietnam) trades under the ticker SPM on HOSE.

Where is SPM Corp. (Vietnam) listed?

SPM Corp. (Vietnam) is listed on HOSE.

Which country or territory is SPM Corp. (Vietnam) listed under?

Our directory records SPM Corp. (Vietnam) under Vietnam.

What does SPM Corp. (Vietnam) do?

Our directory classifies SPM Corp. (Vietnam) as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of SPM Corp. (Vietnam)?

The ISIN recorded for SPM Corp. (Vietnam) is VN000000SPM9.

Does aibio.space cover SPM Corp. (Vietnam)?

aibio.space lists SPM Corp. (Vietnam) among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to SPM Corp. (Vietnam)?

Companies in our directory listed in the same country and business area as SPM Corp. (Vietnam): Nam Ha Pharmaceutical Joint Stock, Imexpharm, Ha Noi CPC1 Pharmaceutical JSC, Pharmedic Pharmaceutical Medicinal JSC, Nova Consumer Group Joint Stock, Tipharco Pharmaceutical Joint Stock Co.

Investor discussion: SPM Corp. (Vietnam)

Members talk about SPM Corp. (Vietnam) (SPM). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HOSE:SPM on TradingView.

Listing details

SPM Corp. (Vietnam) is a public biotech or pharmaceutical company listed on HOSE under the ticker SPM, recorded under Vietnam. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
SPM Corp. (Vietnam)
Ticker
SPM
Listing
HOSE
Country or territory
Vietnam
Business scope
Pharmaceuticals: Major
ISIN
VN000000SPM9
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.